Amazon affiliate link
Alcohol pads
MED PRIDE, 70% isopropyl, 200 count per listing. An alcohol pad does not establish sterility of a research product.
View on Amazon ↗Metabolic and cellular research
NAD+
research guide
NAD+ is a coenzyme central to cellular energy metabolism and DNA repair whose levels decline with age. It is not a peptide. Human trials have tested NAD+ itself and its precursors (nicotinamide riboside, nicotinamide mononucleotide) by oral, sublingual, and intravenous routes in various populations, generally as short-term studies of tolerability, biomarker change, or disease-specific outcomes; large, definitive efficacy trials in healthy adults are still limited.
Evidence depends on population and formulation. Literature summary, not clinical peer review.
Looking for the product? Reign listings and business disclosure ↓
Jorge Abreu is not a doctor. This is an educational research summary, not a prescription or a personal dosing plan. Study results do not establish that a supplier product is safe or effective for people. Consult a licensed clinician about medical decisions.
01 · Start with identity
What is NAD+?
NAD+ is a small-molecule coenzyme, chemically unrelated to peptides, present naturally in all cells. Human studies vary widely by what was actually administered (NAD+ itself, nicotinamide riboside, or nicotinamide mononucleotide), by what tissue compartment was measured (whole blood versus plasma), and by route (oral, sublingual, intravenous), so results are not interchangeable between formulations.
Also searched as: Nicotinamide Adenine Dinucleotide
02 · Read the evidence
What the studies reported
01
IV NAD+ and nicotinamide riboside tolerability differ
A retrospective real-world pilot study comparing intravenous NAD+ infusion to intravenous nicotinamide riboside found differences in reported tolerability between the two, highlighting that NAD+ and its precursors are not equivalent in side-effect profile despite a shared goal of raising NAD+ status. [1]
02
Oral NMN shows a generally favorable short-term safety signal
A systematic review and meta-analysis of randomized controlled trials of oral nicotinamide mononucleotide in adults assessed short-term safety and metabolic outcomes, concluding a broadly favorable tolerability profile in the trials pooled, while metabolic benefit signals were mixed. [2]
03
NAD+ precursor trial in a specific disease population
A randomized controlled trial tested individualized exercise plus an NAD+ precursor in patients with Friedreich's ataxia, illustrating that this rigorous trial design targeted a specific patient population rather than general wellness use. [3]
03 · Numbers in context
What does dosing evidence actually support?
Human trials reviewed used varied routes (oral, sublingual, intravenous) and forms (NAD+, nicotinamide riboside, nicotinamide mononucleotide) in specific study populations such as older adults with cognitive impairment or Friedreich's ataxia patients, generally over weeks to months, with study-selected doses that are not standardized across the field. These figures describe what was tested in each named study, not a general recommendation, and results should not be assumed to transfer between NAD+ and its precursor molecules or between administration routes.
A study dose is not a personal dose. Population, route, formulation and supervision are part of the result. Online community schedules are not treated here as established clinical protocols.
04 · Safety and limits
What not to overlook
- NAD+, nicotinamide riboside, and nicotinamide mononucleotide are related but distinct molecules studied separately; findings for one should not be assumed to apply to another.
- Intravenous and oral/sublingual routes produced different tolerability and blood-level findings in the studies reviewed and are not interchangeable.
- Most rigorous randomized trials located targeted specific disease populations, not general healthy-adult supplementation use.
- Long-term safety data in healthy adults remain limited in the sources reviewed.
05 · Product distinctions
Names are not interchangeable
Commercial research NAD+ is typically sold as a lyophilized powder for reconstitution, separate from the oral precursor supplement products (nicotinamide riboside, nicotinamide mononucleotide) discussed in most clinical literature. Studies cited here tested specific pharmaceutical or supplement-grade preparations; a research vial's formulation, purity, and route are not established as equivalent to any studied product without independent verification.
06 · Handling and storage
Follow validated product instructions
A single water volume, refrigerator temperature or expiry window cannot be assumed for every compound and formulation. Use the exact manufacturer documentation and a validated laboratory procedure. If stability, solvent compatibility or microbiological quality is not documented, those properties remain unverified.
Refrigeration, clear appearance and bacteriostatic water do not make an unverified research product suitable for injection. This guide does not provide a mixing or administration procedure.
The existing concentration calculator checks arithmetic only. It cannot choose a safe dose or establish compatibility, sterility or shelf life.
Reign Peptide · Business disclosure
Research product listings
Jorge Abreu is involved in Reign Peptide. Links to Reign are a business connection, not an independent endorsement. Reign lists these products for laboratory research, not human consumption.
Use the listing to check the labeled identity, amount and available batch documentation. A purity result alone does not verify sterility, clinical suitability or equivalence to a medicine used in a trial.
Names and sizes are product labels, not dosing recommendations. Confirm current details with the seller.
Supplies and accessories
Compare the actual specifications
Jorge's supply directory includes syringes, alcohol pads, storage cases, travel refrigeration and electrolytes, with separate links for the two travel refrigeration options. Accessory availability is not a recommendation to administer a research compound.
Affiliate disclosure: As an Amazon Associate I earn from qualifying purchases.
Amazon affiliate link
Peptide fridge case
Listing: 63 slots for 3mL bottles, bag only. An organizer is not active refrigeration or a validated storage system.
View on Amazon ↗Amazon affiliate link
Peptide travel case
Medineed travel case with temperature display and two ice packs per listing. Check dimensions and transport requirements.
View on Amazon ↗Questions still worth asking
What remains unresolved?
- Do the biomarker changes seen with oral or IV NAD+-boosting strategies translate into meaningful clinical outcomes in healthy adults over the long term?
- Which route and precursor form (NAD+ itself versus NR versus NMN) most reliably raises tissue NAD+ levels, and does this differ by population studied?
Check the source
References and evidence scope
- Human observational study · 2026Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting ↗
- Systematic review and meta-analysis · 2026Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis ↗
- Human trial · 2026Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 x 2 factorial, randomised controlled trial ↗
These are the sources reviewed for this page, not an exhaustive systematic review. Related compound research is identified as such. Product links are not scientific references.
Keep reading